[go: up one dir, main page]

PL333056A1 - Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug - Google Patents

Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug

Info

Publication number
PL333056A1
PL333056A1 PL97333056A PL33305697A PL333056A1 PL 333056 A1 PL333056 A1 PL 333056A1 PL 97333056 A PL97333056 A PL 97333056A PL 33305697 A PL33305697 A PL 33305697A PL 333056 A1 PL333056 A1 PL 333056A1
Authority
PL
Poland
Prior art keywords
loratadin
hyperaemia
composition intended
treat asthma
reducing drug
Prior art date
Application number
PL97333056A
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PL333056A1 publication Critical patent/PL333056A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL97333056A 1996-10-31 1997-10-29 Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug PL333056A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31

Publications (1)

Publication Number Publication Date
PL333056A1 true PL333056A1 (en) 1999-11-08

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97333056A PL333056A1 (en) 1996-10-31 1997-10-29 Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug

Country Status (21)

Country Link
EP (1) EP0941091A1 (en)
JP (1) JP2000505104A (en)
KR (1) KR20000052922A (en)
CN (1) CN1235545A (en)
AR (1) AR008908A1 (en)
AU (1) AU731756B2 (en)
BR (1) BR9712705A (en)
CA (1) CA2268546A1 (en)
CO (1) CO4910128A1 (en)
CZ (1) CZ150999A3 (en)
HU (1) HUP9904075A3 (en)
ID (1) ID23431A (en)
IL (1) IL129662A0 (en)
NO (1) NO992062D0 (en)
NZ (1) NZ335078A (en)
PE (1) PE11399A1 (en)
PL (1) PL333056A1 (en)
SK (1) SK54599A3 (en)
TR (1) TR199901003T2 (en)
WO (1) WO1998018470A1 (en)
ZA (1) ZA979731B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1205799A (en) * 1997-10-29 1999-05-17 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (en) * 1998-07-28 2001-02-23 Nicox Sa SALTS OF NITRIC ACID WITH ACTIVE DRUGS IN THE TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM
PA8481801A1 (en) * 1998-09-10 2000-09-29 Schering Corp METHODS AND COMPOSITIONS FOR TREATING SINUSITIS, OTITIS MEDIA AND OTHER RELATED DISORDERS USING ANTIHISTAMINES
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (en) * 1999-02-23 2005-08-01 주식회사유한양행 Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
CN1161112C (en) * 1999-02-23 2004-08-11 株式会社柳韩洋行 Pharmaceutical capsule composition containing loratadine and pseudoephedrine
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
SK287684B6 (en) * 1999-12-20 2011-06-06 Schering Corporation Sustained release solid oral pharmaceutical dosage composition
SK287105B6 (en) * 1999-12-20 2009-12-07 Schering Corporation Bilayer sustained release oral dosage composition
AU4248400A (en) * 2000-04-14 2001-10-30 J Med Pharmaceuticals Inc Single-dose antihistamine/decongestant formulations for treating rhinitis
BR0111018A (en) * 2000-05-25 2004-02-17 Schering Corp Liquid and solid stable formulations
EP1401444A1 (en) * 2001-06-20 2004-03-31 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
RU2423979C2 (en) * 2005-06-17 2011-07-20 АФТ Фармасьютикалз Лимитед Novel pharmaceutic composition and its application in method of treatment of patients with hyperaemia and edema of mucous membrane of upper airways
NZ588134A (en) * 2005-06-17 2010-11-26 Aft Pharmaceuticals Ltd Novel pharmaceutical for use in a method for treatment of upper respiratory mucosal congestion
TWI411451B (en) * 2006-06-01 2013-10-11 Msd Consumer Care Inc Phenylephrine pharmaceutical formulations and compositions for colonic absorption
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (en) * 2014-02-24 2015-07-28 성균관대학교산학협력단 Composition comprising Loratadine for anti-inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
JP2000505104A (en) 2000-04-25
EP0941091A1 (en) 1999-09-15
NO992062L (en) 1999-04-29
HUP9904075A2 (en) 2000-05-28
KR20000052922A (en) 2000-08-25
SK54599A3 (en) 2000-08-14
AR008908A1 (en) 2000-02-23
WO1998018470A1 (en) 1998-05-07
IL129662A0 (en) 2000-02-29
BR9712705A (en) 1999-10-26
ZA979731B (en) 1998-04-29
AU4995397A (en) 1998-05-22
AU731756B2 (en) 2001-04-05
CO4910128A1 (en) 2000-04-24
HUP9904075A3 (en) 2002-02-28
NO992062D0 (en) 1999-04-29
CZ150999A3 (en) 1999-10-13
ID23431A (en) 2000-04-20
NZ335078A (en) 2000-10-27
CA2268546A1 (en) 1998-05-07
CN1235545A (en) 1999-11-17
PE11399A1 (en) 1999-02-09
TR199901003T2 (en) 1999-07-21

Similar Documents

Publication Publication Date Title
PL333056A1 (en) Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug
CZ161599A3 (en) N-substituted 2-cynopyrrolidines, process of their preparation and their utilization as medicaments
ZA959321B (en) Process for purifying and isolating 2'-deoxy-2',2'-difluo-ronucleosides
GB9419536D0 (en) Medicaments
ZA952356B (en) Skin treatment composition
EP0803255A4 (en) Medicinal composition
PL335555A1 (en) Novel compounds - substituted benzamides and therapeutic agent
GB9406573D0 (en) Medicaments
GB9420784D0 (en) Medicaments
ZA952121B (en) Skin treatment composition
HU9500910D0 (en) Pyrazoline-derivatives and their use as plant desease-controlling agent
PL338123A1 (en) 6-pyrrolydin-2-ylpyridines, their production and application in therapy
AU3982695A (en) Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
GB9418530D0 (en) Medicaments
GB9405046D0 (en) Skin treatment composition
GB9416365D0 (en) Medicaments
GB9411052D0 (en) Medicaments
GB2291807B (en) Improvements in or relating to breathing devices
EP0790829A4 (en) Medicaments
GB9825972D0 (en) Improvements in medicaments for asthma treatment
SI0991650T1 (en) Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy
GB9707589D0 (en) Improvements in and relating to treatment
ZW1194A1 (en) Therapeutic agent
GB9406278D0 (en) Therapeutic agent
GB9615546D0 (en) Improvements in and relating to the treatment of multiple sclerosis, and muscle spasms